First use of triple immunotherapy in brain cancer paves way for clinical trial

by

An experimental treatment for an aggressive and lethal brain cancer has been published in Nature Medicine, paving the way for a clinical trial to be conducted by researchers at The Brain Cancer Center.

Leave A Comment

Your email address will not be published. Required fields are marked *